About
Neuronano AB develops ultrathin, flexible electrode cluster technology and biodegradable carrier implants for deep brain stimulation aimed at treating neurological conditions such as Parkinson’s disease, pain, and epilepsy; their products are in preclinical testing in collaboration with Lund University and Aarhus University.
Explore Neuronano AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.